Riskpilot← Back to searchSign inGet full accessGenomeVault AB
ABActiveOrg 5595320549Research and experimental development on natural sciences and engineering · NACE 7210Est. 20251-4 employees
Revenue
—
EBITDA margin
—
Equity ratio
—
Financial strength
Net profit
—
| Revenue | — | — |
| EBITDA | — | — |
| Net profit | — | — |
| Total assets | — | — |
| Equity | — | — |
| Employees | — | — |
Legal name
GenomeVault AB
Org number
5595320549
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
23 maj 2025
Share capital
—
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
—
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska bedriva miljöövervakning och analys genom miljö- DNA (eDNA), med fokus på högkapacitets DNA-klassificering för att bedöma biologisk mångfald, identifiera invasiva arter och övervaka ekologiska förändringar. Bolaget tillhandahåller även rapporter och konsulttjänster inom miljöförvaltning, naturvård och forskning.
Address
Email
theo@genomevault.net
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item |
|---|
| Revenue |
| Staff expenses |
| EBITDA |
| Depreciation & amort. |
| EBIT |
| Net financials |
| Profit before tax |
| Tax |
| Net profit |
| Item |
|---|
| Total assets |
| Equity |
| Long-term debt |
| Short-term debt |
| Total debt |
EBITDA margin
%
This company
15.8%
Market median
-NaN% vs market
Equity ratio
%
This company
38.2%
Market median
-NaN% vs market
Return on equity
%
This company
18.4%
Market median
-NaN% vs market
Net profit margin
%
This company
8.1%
Market median
-NaN% vs market
Asset turnover
×
This company
1.12×
Market median
-NaN% vs market
Debt / equity
×
This company
0.62×
Market median
-NaN% vs market
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PT Chief Executive Officer | Chief Executive Officer | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2026 | |
| Board of Directors | 2025 | |
| Former (1) | ||
| Deputy Board Member | 2025 – 2026 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of GenomeVault AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Phanu Theodore Serivichyaswat | Chief Executive Officer | 0 companies |
| Björn Magnus Ursing | Chairman | 0 companies |
| Tom Jürgen van der Valk | Board of Directors | 0 companies |
| Love Gunnar Dalén | Deputy Board Member | 0 companies |